Rong Zhang, MD
Rong Zhang, MD
Vice Chief
Cancer Hospital, Chinese Academy of Medical Sciences
Panjianyuan nanli 17#, Chaoyang District
Beijing
China
100021
Papers:
435
Recurrent ovarian cancer patients with 3-6 month treatment-free interval or 1-2 prior chemotherapy regimens might get benefit from tumor chemosensitivity assay directed chemotherapy